Adventrx Pharmaceuticals, Inc. has entered into an agreement with Pharmatek Laboratories for the manufacture of ANX-201 (Thiovir) capsules for clinical studies. “Pharmatek is an experienced contract manufacturer and we are confident in their ability to produce reliable cGMP material for our clinical trials,” said Michele Yelmene, vice president of regulatory affairs. “The drug supply they generate under this contract is expected to provide the company with inventory for ou...